The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis

Summary

Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also gives rise to subsequent challenges in caregiving, affecting both the patients' families and society.

Timeline

Start

2022-06-14

Primary completion

2025-06-13

Completion

2025-06-13

Drugs

Indications